152 results on '"Miravitlles, Marc"'
Search Results
2. miR-320c Regulates SERPINA1 Expression and Is Induced in Patients With Pulmonary Disease
3. HLA-DRB1 Alleles are Associated With COPD in a Latin American Admixed Population
4. Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain
5. Changes in Control Status of COPD Over Time and Their Consequences: A Prospective International Study
6. Results of a Diagnostic Procedure Based on Multiplex Technology on Dried Blood Spots and Buccal Swabs for Subjects With Suspected Alpha1 Antitrypsin Deficiency
7. Prevalence and Determinants of COPD in Spain: EPISCAN II
8. Blood Eosinophil Counts and Their Variability and Risk of Exacerbations in COPD: A Population-Based Study
9. Clinical characteristics and risk of exacerbations associated with different diagnostic criteria of asthma-COPD overlap
10. Serum Levels of Alpha1-antitrypsin and Their Relationship With COPD in the General Spanish Population
11. Patients With Chronic Obstructive Pulmonary Disease Exacerbations: Recommendations for Diagnosis, Treatment and Care
12. 10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain—A Summary of the EPISCAN II Protocol
13. Recommendations on Non-Pharmacological Treatment in Chronic Obstructive Pulmonary Disease From the Spanish COPD Guidelines (GesEPOC 2017)
14. Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes
15. Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (GesEPOC): The Epoconsul Study
16. Accuracy of a New Algorithm to Identify Asthma–COPD Overlap (ACO) Patients in a Cohort of Patients with Chronic Obstructive Airway Disease
17. Consensus on the Asthma–COPD Overlap (ACO) Between the Spanish COPD Guidelines (GesEPOC) and the Spanish Guidelines on the Management of Asthma (GEMA)
18. Spanish COPD Guidelines (GesEPOC) 2017. Pharmacological Treatment of Stable Chronic Obstructive Pulmonary Disease
19. Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency: Database Evaluation and Population Analysis
20. Prevalence and Perception of 24-h Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain
21. Characteristics of Candidates for Lung Transplantation Due to Chronic Obstructive Pulmonary Disease and Alpha-1 Antitrypsin Deficiency Emphysema
22. Indications for Active Case Searches and Intravenous Alpha-1 Antitrypsin Treatment for Patients With Alpha-1 Antitrypsin Deficiency Chronic Pulmonary Obstructive Disease: An Update
23. “Correct Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease”: A Consensus Document
24. Spanish Guideline for COPD (GesEPOC). Update 2014
25. Underdiagnosis of Chronic Obstructive Pulmonary Disease in Women: Quantification of the Problem, Determinants and Proposed Actions
26. Quality and Strength: The GRADE System for Formulating Recommendations in Clinical Practice Guidelines
27. GesEPOC 2021 and GOLD 2021. Closer together or further apart?
28. WITHDRAWN: Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome
29. Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD
30. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2019 Report: Future Challenges
31. Spanish implementation of the new international alpha-1 anitrypsin deficiency international registry: The European Alpha-1 Research Collaboration (EARCO)
32. GesEPOC 2021: One More Step Towards Personalized Treatment of COPD
33. Clinical control in COPD: A New therapeutic objective?
34. Serum Levels of Alpha1-antitrypsin and Their Relationship With COPD in the General Spanish Population
35. Pulmonary rehabilitation… yes but no
36. Multidisciplinary Perspectives on the Importance of Physical Activity in COPD
37. Are There Differences Between the Available Treatments for Emphysema Associated With Alpha-1 Antitrypsin Deficiency?
38. Augmentation Therapy for Emphysema due to Alpha-1 Antitrypsin Deficiency: Pro
39. Safety of Rehabilitation Program for COPD Patients
40. GOLD in 2017: A View From the Spanish COPD Guidelines (GesCOPD)
41. How can Patients With Asthma-COPD Overlap Syndrome in Clinical Practice be Identified?
42. What was the Impact of the Spanish COPD Guidelines (GesEPOC) and how can They be Improved?
43. In Response to: Martínez-Velilla N. GesEPOC Guidelines and Elderly Patients
44. Alpha-1-Antitrypsin Deficiency Associated With the Mattawa Variant
45. The General Public's Knowledge of Chronic Obstructive Pulmonary Disease and Its Determinants: Current Situation and Recent Changes
46. Consensus Document on the Overlap Phenotype COPD–Asthma in COPD
47. Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD
48. Reliability of a Self-Administered Diary of Symptoms for Assessing the Evolution of Acute Bronchitis
49. Clinical Phenotypes of COPD: Identification, Definition and Implications for Guidelines
50. Factors Associated With Hospital Admission for Exacerbation of Chronic Obstructive Pulmonary Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.